Shenzhen: Full coverage for hospitalization expenses for new crown infections from January 8 to March 31

Read Time:4 Minute, 42 Second

According to the Shenzhen Health Care Commission official microblogging news, January 8, the implementation of the new coronavirus infection “Class B B tube”, how to report patients medical insurance?

According to the spirit of the relevant documents of the National and Provincial Medical Insurance Bureau, the Municipal Medical Insurance Bureau quickly implemented the policy of optimizing the medical coverage of patients with new coronavirus infections after the implementation of “Class B, B management”, and during the period from January 8 to March 31, 2023, patients with new coronavirus infections will be fully covered by hospitalization expenses, Paxlovid , Azivudine tablets, Monoravir capsules, Disseminated Cold and Dampness granules and more than 700 kinds of drugs can be reimbursed 85%.

Full coverage of hospitalization costs, first implemented until March 31, 2023

According to the Municipal Health Insurance Bureau, patients with neo-coronavirus infection incurred in all admitting medical institutions, in line with the new coronavirus infection diagnosis and treatment plan developed by the health and health departments, the implementation of the prior cost protection policy, by the basic medical insurance, major medical insurance, medical assistance and other payments in accordance with the provisions, the personal burden of the part of the financial subsidies. The policy is calculated by the time of admission of patients with new coronavirus infection, the first implementation until March 31, 2023.

At the same time, Shenzhen has implemented a special guarantee that the medical expenses related to the treatment of neo-coronavirus infection within the scope of the medical insurance catalog incurred by patients with neo-coronavirus infection and suspected symptoms in outpatient and emergency medical institutions at the second level or below, will be paid 85% by the basic medical insurance major medical fund, with no starting line and no ceiling line, and individual out-of-pocket expenses can be paid by the balance of the participant’s personal account according to the regulations. This policy is effective from the date of implementation of the new coronavirus infection “B class B management” (i.e. from January 8, 2023) and will be implemented until March 31, 2023.

The outpatient and emergency treatment costs for NCCV infection incurred by the insured patients in the designated medical institutions of tertiary medical insurance will be implemented in accordance with the general outpatient coordination policy of Shenzhen.

Implementation of the temporary medical insurance drug list, outpatient and emergency medical care can be reimbursed 85%

For the scope of payment of medical expenses for patients with NCCV, Shenzhen has temporarily expanded the medical insurance drug list in accordance with national and provincial requirements, and implemented it first until March 31, 2023. Specific provisions are as follows.

patients with neo-coronavirus infection incurring inpatient treatment costs are not restricted by the medical insurance drug list and are all included in the scope of payment for medical insurance.
Patients with neo-coronavirus infection and suspected symptoms can be reimbursed 85% for the use of drugs in the “Guangdong Province Basic Medical Insurance Outpatient Drug Catalogue for the Treatment of Novel Coronavirus Infection” in outpatient and emergency medical institutions at the second level or below, and more than 700 drugs such as Paxlovid, Azulfidine tablets, Monoravir capsules and Dispersing Cold and Dampness granules have been included in the catalog.

Patients with the new coronavirus infection are reimbursed in accordance with Shenzhen’s normal medical insurance policy for the use of medical insurance drugs outside the “Guangdong Province Basic Medical Insurance Outpatient Drug Catalogue for the Treatment of New Coronavirus Infection” at various medical institutions.

The Municipal Medical Insurance Bureau also includes the medical expenses related to the new coronavirus infection incurred by the insured patients in the first consultation on the Internet+ into the scope of medical insurance online payment, and the reimbursement standard is the same as offline. The reimbursement policy for NICU-related symptoms will be implemented in accordance with the current Internet reimbursement policy.

Participants can make up for the failure to properly bill due to objective reasons

In addition, in order to fully protect the rights and interests of the participants, in accordance with the spirit of national and provincial documents, the Municipal Medical Insurance Bureau requires that since the implementation of the new coronavirus infection “Class B B management” date (i.e., January 8, 2023), eligible for treatment in Shenzhen participants have incurred compliance medical expenses, due to objective reasons can not be properly recorded, the designated Medical institutions should handle the procedures for the settlement of their accounts in accordance with the regulations.

An example –

Q: A Wei went to see the new crown clinic on January 10, medical expenses were not reimbursed according to the special protection treatment, now can still enjoy the treatment retroactive reimbursement?

A: Yes.

Shenzhen implementation of the implementation of the “Class B B tube” after optimizing the new coronavirus infection patient expenses related to medical security policy since January 8, 2023 implementation, eligible for treatment after January 8, the participant has incurred in compliance with the medical expenses, due to objective reasons can not be properly accounted for, the designated medical institutions should be in accordance with the provisions of The medical institution shall carry out the billing procedures for them.

The Municipal Medical Insurance Bureau will continue to provide convenient medical insurance services, implement the policy of “long prescription” medical insurance payment for chronic diseases, and gradually promote the direct settlement of medical expenses for “new crown outpatient” in different places. The company is also a member of the Board of Directors of the National Association of Medical Insurance Companies (NAMIC). The company’s main goal is to provide a comprehensive range of services to its customers.